Possibilities of dispensary observation in reducing mortality from coronary heart disease

Cover Page

Cite item

Full Text

Abstract

Dispensary observation of patients with coronary artery disease can significantly reduce the likelihood of cardiovascular complications onset. Active outpatient monitoring allows to correct the main risk factors for cardiovascular complications, to estimate the risk of unfavorable cardiovascular events onset and to identificate patients who will get benefit of coronary revascularization. The introduction of a comprehensive assessment of cardiovascular risk and the development of remote monitoring technologies will improve the long-term results of outpatient follow-up of patients with coronary artery disease at high cardiovascular risk.

About the authors

Sergey A. Boytsov

Chazov National Medical Research Center of Cardiology; Yevdokimov Moscow State University of Medicine and Dentistry

Email: semaver@yandex.ru
ORCID iD: 0000-0001-6998-8406

акад. РАН, д-р мед. наук, проф., ген. дир.; проф. каф. поликлинической терапии

Russian Federation, Moscow; Moscow

Sergei I. Provatorov

Chazov National Medical Research Center of Cardiology

Author for correspondence.
Email: semaver@yandex.ru
ORCID iD: 0000-0002-7936-3634

д-р мед. наук, вед. науч. сотр. отд. легочной гипертензии и заболеваний сердца

Russian Federation, Moscow

References

  1. Российский статистический ежегодник. 2021: Статистический сборник Росстат. M., 2021. Режим доступа: https://rosstat.gov.ru/storage/mediabank/Ejegodnik_2021.pdf. Ссылка активна на 14.11.2022 [Russian statistical yearbook. 2021: Statistical collection of Rosstat. Moscow, 2021 Available at: https://rosstat.gov.ru/storage/mediabank/Ejegodnik_2021.pdf. Accessed: 14.11.2022 (in Russian)].
  2. Sorbets E, Fox KM, Elbez Y, et al. CLARIFY investigators. Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry. Eur Heart J. 2020;41(3):347-56. doi: 10.1093/eurheartj/ehz660
  3. Rapsomaniki E, Shah A, Perel P, et al. Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients. Eur Heart J. 2014;35(13):844-52. doi: 10.1093/eurheartj/eht533
  4. Шальнова С.А., Оганов Р.Г., Деев А.Д., и др. Сочетания ишемической болезни сердца с другими неинфекционными заболеваниями в популяции взрослого населения: ассоциации с возрастом и факторами риска. Кардиоваскулярная терапия и профилактика. 2015;14(4):44-51 [Shalnova SA, Oganov RG, Deev AD, et al. Comorbidities of ischemic heart disease with other non-communicable diseases in adult population: age and risk factors association. Cardiovascular Therapy and Prevention. 2015;14(4):44-51 (in Russian)]. doi: 10.15829/1728-8800-2015-4-44-51
  5. Bauters C, Tricot O, Meurice T, et al. Long-term risk and predictors of cardiovascular death in stable coronary artery disease: the CORONOR study. Coron Artery Dis. 2017; 28(8):636-41. doi: 10.1097/MCA.0000000000000560
  6. Abbadi AB, Lemesle G, Lamblin N, Bauters C. Very long-term outcomes of older adults with stable coronary artery disease (from the CORONOR study). Coron Artery Dis. 2022;33(3):169-75. doi: 10.1097/MCA.0000000000001086
  7. Viana-Tejedor A, Loughlin G, Fernández-Avilés F, Bueno H. Temporal trends in the use of reperfusion therapy and outcomes in elderly patients with first ST elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2015;4(5):461-7. doi: 10.1177/2048872614565928
  8. Terkelsen CJ, Lassen JF, Nørgaard BL, et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J. 2005;26(1):18-26. doi: 10.1093/eurheartj/ehi002
  9. Lamblin N, Meurice T, Tricot O, et al. First Hospitalization for Heart Failure in Outpatients With Stable Coronary Artery Disease: Determinants, Role of Incident Myocardial Infarction, and Prognosis. J Card Fail. 2018;24(12):815-22. doi: 10.1016/j.cardfail.2018.09.013
  10. Blanke P, Naoum C, Ahmadi A, et al. Long-Term Prognostic Utility of Coronary CT Angiography in Stable Patients With Diabetes Mellitus. JACC Cardiovasc Imaging. 2016;9(11):1280-8. doi: 10.1016/j.jcmg.2015.12.027
  11. Lima EG, Charytan DM, Hueb W, et al. Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial. Nephrol Dial Transplant. 2020;35(8):1369-76. doi: 10.1093/ndt/gfy379
  12. Российское кардиологическое общество (РКО). Стабильная ишемическая болезнь сердца. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11):4076 [Russian Society of Cardiology (RSC). 2020 Clinical practice guidelines for Stable coronary artery disease. Russian Society of Cardiology (RSC). 2020 Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2020;25(11):4076 (in Russian)]. doi: 10.15829/1560-4071-2020-4076
  13. Knuuti J, Wijns W, Saraste A, et al. ESC Scientific Document Group, 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2020;41(3):407-77. doi: 10.1093/eurheartj/ehz425
  14. Lindholm D, Lindbäck J, Armstrong PW, et al. Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease. J Am Coll Cardiol. 2017;70(7):813-26. doi: 10.1016/j.jacc.2017.06.030
  15. Самородская И.В., Чернявская Т.К., Какорина Е.П., Семенов В.Ю. Ишемические болезни сердца: анализ медицинских свидетельств о смерти. Российский кардиологический журнал. 2022;27(1):4637 [Samorodskaya IV, Chernyavskaya TK, Kakorina EP, Semenov VYu. Ischemic heart disease: medical certificate of cause of death analysis. Russian Journal of Cardiology. 2022;27(1):4637 (in Russian)]. doi: 10.15829/1560-4071-2022-4637
  16. Sawicki OA, Mueller A, Glushan A, et al. Intensified ambulatory cardiology care: effects on mortality and hospitalisation – a comparative observational study. Sci Rep. 2020;10(1):14695. doi: 10.1038/s41598-020-71770-9
  17. Приказ Министерства здравоохранения Российской Федерации от 15.03.2022 №168н «Об утверждении порядка проведения диспансерного наблюдения за взрослыми». Российская газета. 22.04.2022. Режим доступа: https://rg.ru/documents/2022/04/22/minzdrav-prikaz168-site-dok.html. Ссылка активна на 14.11.2022 [Order of the Ministry of Health of the Russian Federation dated March 15, 2022 №168n “On approval of the procedure for dispensary observation of adults”. Russian newspaper. 04.22.2022. Available at: https://rg.ru/documents/2022/04/22/minzdrav-prikaz168-site-dok.html. Accessed: 14.11.2022 (in Russian)].
  18. Приказ Министерства здравоохранения Российской Федерации от 29.09.2022 №639н «Об утверждении перечня лекарственных препаратов для медицинского применения в целях обеспечения в амбулаторных условиях лиц, находящихся под диспансерным наблюдением, которые перенесли острое нарушение мозгового кровообращения, инфаркт миокарда, а также которым выполнены аортокоронарное шунтирование, ангиопластика коронарных артерий со стентированием и катетерная абляция по поводу сердечно-сосудистых заболеваний, в течение 2 лет с даты постановки диагноза и (или) выполнения хирургического вмешательства». Российская газета. 28.10.2022. Режим доступа: https://rg.ru/documents/2022/10/28/minzdrav-prikaz639-site-dok.html. Ссылка активна на 14.11.2022 [Order of the Ministry of Health of the Russian Federation dated September 29, 2022 №639n “On approval of the list of drugs for medical use in order to provide outpatient care for people under dispensary observation who have suffered acute cerebrovascular accident, myocardial infarction, and who have undergone coronary artery bypass grafting, angioplasty of the coronary arteries with stenting and catheter ablation for cardiovascular diseases, within 2 years from the date of diagnosis and (or) surgical intervention”. Russian newspaper. 10.28.2022. Available at: https://rg.ru/documents/2022/10/28/minzdrav-prikaz639-site-dok.html. Accessed: 14.11.2022 (in Russian)].
  19. Luiza VL, Chaves LA, Silva RM, et al. Pharmaceutical policies: effects of cap and co-payment on rational use of medicines. Cochrane Database Syst Rev. 2015;2015(5):CD007017. doi: 10.1002/14651858.CD007017.pub2
  20. Mills EJ, O'Regan C, Eyawo O, et al. Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients. Eur Heart J. 2011;32(11):1409-15. doi: 10.1093/eurheartj/ehr035
  21. Espinoza C, Mukherjee D. Dual Antiplatelet Therapy in Patients with High Cardiovascular Risk. Heart Int. 2021;15(1):26-36. doi: 10.17925/HI.2021.15.1.26
  22. Порядок оказания медицинской помощи больным с сердечно-сосудистыми заболеваниями. Российская газета. 24.04.2013. Режим доступа: https://rg.ru/documents/2013/04/25/serdechniki-dok.html. Ссылка активна на 14.11.2022 [The procedure for providing medical care to patients with cardiovascular diseases. Russian newspaper. 04.24.2013. Available at: https://rg.ru/documents/2013/04/25/serdechniki-dok.html. Accessed: 14.11.2022 (in Russian)].
  23. Осокина А.К, Потехина А.В, Филатова А.Ю., и др. Возможность контроля липидного профиля у пациентов, перенесших стентирование коронарных артерий, с помощью дистанционного мониторинга по результатам наблюдения в течение 6 месяцев. Вестник Всероссийского общества специалистов по медико- социальной экспертизе, реабилитации и реабилитационной индустрии. 2020;3:56-64 [Osokina AK, Potekhina AV, Filatova AYu, et al. Possibility of lipid profile control in patients under coronary stenting using remote monitoring on the results of observation for 6 months. Vestnik of Russian Society of Specialists on Medical Social Expertise and Rehabilitation Industry. 2020;3:56-64 (in Russian)]. doi: 10.17238/issn1999-2351.2020.3.56-64
  24. Alsadat N, Hyun K, Boroumand F, et al. Achieving lipid targets within 12 months of an acute coronary syndrome: an observational analysis. Med J Aust. 2022;216(9):463-8. doi: 10.5694/mja2.51442
  25. Hachamovitch R, Hayes SW, Friedman JD, et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107(23):2900-7. doi: 10.1161/01.CIR.0000072790.23090.41
  26. Elbez Y, Cheong AP, Fassa AA, et al. Clinical outcomes in patients with stable coronary artery disease with vs. without a history of myocardial revascularization. Eur Heart J Qual Care Clin Outcomes. 2016;2(1):23-32. doi: 10.1093/ehjqcco/qcv017
  27. Boden WE, O'Rourke RA, Maron DJ, et al. Optimal Medical Therapy with or without PCI for Stable Coronary Disease. N Engl J Med. 2007;356:1503-16. doi: 10.1056/NEJMoa070829
  28. Maron DJ, Hochman JS, Reynolds HR, et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020;382:1395-407. doi: 10.1056/NEJMoa1915922

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2023 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies